CVE-2021-20853

CVE-2021-20853 is a medium-severity vulnerability in Elecom Wrh-733gbk Firmware with a CVSS 3.x base score of 6.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-78.

Key facts

Description

ELECOM LAN routers (WRH-733GBK firmware v1.02.9 and prior and WRH-733GWH firmware v1.02.9 and prior) allows a network-adjacent attacker with an administrator privilege to execute arbitrary OS commands via unspecified vectors.

Frequently asked questions

What is CVE-2021-20853?
ELECOM LAN routers (WRH-733GBK firmware v1.02.9 and prior and WRH-733GWH firmware v1.02.9 and prior) allows a network-adjacent attacker with an administrator privilege to execute arbitrary OS commands via unspecified vectors.
How severe is CVE-2021-20853?
CVE-2021-20853 has a CVSS 3.x base score of 6.8, rated medium severity. It is exploitable over an adjacent network with low attack complexity, requires high privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2021-20853 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (34th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2021-20853?
CVE-2021-20853 primarily affects Elecom Wrh-733gbk Firmware. In total, 2 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2021-20853?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2021-20853 published?
CVE-2021-20853 was published on 2021-12-01 and last updated on 2026-06-17.

References

Affected products (2)

More vulnerabilities in Elecom Wrh-733gbk Firmware

All CVEs affecting Elecom Wrh-733gbk Firmware →

Other CWE-78 (OS Command Injection) vulnerabilities

Browse all CWE-78 (OS Command Injection) vulnerabilities →